Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency

Condition:   Ureteral Injury,Interventions:   Drug: sodium fluorescein;   Drug: phenazopyridineSponsors:   University Hospital Case Medical Center;   Megan Billow;   Graham Chapman;   Sangeeta Mahajan;   Alex Soriano;   Sherif El-NasharNot yet recruiting - verified April 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials